Low Vision Occupational Therapy in Parkinson's Disease

Parkinson Disease Clinical Trial

Official title:

Low Vision Occupational Therapy in Parkinson's Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04127838
• Other study ID #: IRB-300003853
• Status: Completed
• Phase: N/A
• Start date: October 16, 2019
• Est. completion date: June 3, 2022

Study information

• Verified date: June 2022
• Source: University of Alabama at Birmingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary aim of this study is to determine whether low-vision occupational therapy improves quality of life in Parkinson's Disease (PD) patients. Low-vision occupational therapy has not been previously studied in PD patients, and we suspect that this is a beneficial treatment option for PD patients as vision impairment is common in the PD patient population. Our primary objective will assess whether quality of life was improved following a low-vision occupational therapy session.

Description:

This project will be an exploratory study that will evaluate the benefits of low vision occupational therapy in the treatment of PD using the Revised Self-Report Assessment of Functional Visual Performance (R-SRAFVP) as the primary outcome measure. This tool assesses 33 vision-dependent ADLs ranging from personal care, leisurely activities, clothing management, meal preparation, etc. Patients are able to rank their ability to complete these tasks as independent, minimally difficult, moderately difficult, greatly difficult, unable, or not applicable. This will allow us to capture potential changes in the patient's ability to complete vision-specific ADLs following low vision occupational therapy. In addition, we will also evaluate quality of life using the Parkinson's Disease Questionnaire (PDQ-39), to compare this broad outcome measure with the R-SRAFVP.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 33
• Est. completion date: June 3, 2022
• Est. primary completion date: May 13, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 and older

• seen at UAB Movement Disorders Clinic

• diagnosis of idiopathic Parkinson's Disease

• able to read, speak, and understand spoken English.

Exclusion Criteria:

• minors

• cognitively impaired

Related Conditions & MeSH terms

• Parkinson Disease
• Vision, Low

Intervention

Behavioral:
• Low Vision Occupational Therapy
Occupational therapy may include methods to effectively modify environments (such as addition of task lighting), training in the use of assistive technology (such as voice activated devices), teaching new skills (such as sensory substitution) and prevention of accidents and injury (such as home safety modifications).

Locations

Country	Name	City	State
United States	University of Alabama at Birmingham	Birmingham	Alabama

Sponsors (1)

Lead Sponsor	Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Activities of Daily Living	Revised Self-Report Assessment of Functional Visual Performance (R-SRAFVP). This tool assesses 33 vision-dependent ADLs ranging from personal care, leisurely activities, clothing management, meal preparation, etc. Patients are able to rank their ability to complete these tasks as independent, minimally difficult, moderately difficult, greatly difficult, unable, or not applicable.	Changes measured in the R-SRAFVP from the initial visit as compared to the visit six months later.
Secondary	Change in quality of life	Parkinson's Disease Questionnaire (PDQ-39); The PDQ-39 assesses how often people affected by Parkinson's experience difficulties across 8 dimensions of daily living including relationships, social situations and communication	Changes measured in the PDQ-39 from the initial visit as compared to the visit six months later.